| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 35 |
| 1 | LETROZOLE TABLETS | 32 |
| 2 | BEVACIZUMAB | 28 |
| 3 | CARBOPLATIN | 21 |
| 4 | PACLITAXEL | 21 |
| 5 | ANASTROZOLE | 20 |
| 6 | ANASTROZOLE TABLETS | 16 |
| 7 | CISPLATIN | 15 |
| 8 | GEMCITABINE | 14 |
| 9 | GEMCITABINE HYDROCHLORIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARIUM SULFATE | 1 | 0.0023 |
| 1 | DARIFENACIN HYDROBROMIDE | 1 | 0.0012 |
| 2 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 3 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 2 | 0.0008 |
| 4 | ANASTROZOLE TABLETS | 16 | 0.0007 |
| 5 | LETROZOLE TABLETS | 32 | 0.0007 |
| 6 | SARGRAMOSTIM | 1 | 0.0006 |
| 7 | LETROZOLE | 35 | 0.0006 |
| 8 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 9 | ANASTROZOLE | 20 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 40 |
| 1 | Platinum-based Drug [EPC] | 39 |
| 2 | Microtubule Inhibitor [EPC] | 29 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 28 |
| 4 | Kinase Inhibitor [EPC] | 26 |
| 5 | Corticosteroid [EPC] | 24 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 19 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 8 | Benzodiazepine [EPC] | 12 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 40 | 0.0004 |
| 1 | Microtubule Inhibitor [EPC] | 29 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 28 | 0.0002 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 7 | 0.0001 |
| 4 | Platinum-based Drug [EPC] | 39 | 0.0001 |
| 5 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 3 | 0.0001 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 19 | 0.0001 |
| 9 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |